123 related articles for article (PubMed ID: 4997883)
1. [Immunologic analysis of tyrosinase in malignant melanoma, nevi and clinically normal skin].
Herrmann WP
Arch Dermatol Forsch; 1971; 241(1):65-74. PubMed ID: 4997883
[No Abstract] [Full Text] [Related]
2. Immunologic homogeneity and electrophoretic heterogeneity of mouse melanoma tyrosinases.
Otaki N; Miyazaki K
J Invest Dermatol; 1973 Dec; 61(6):339-43. PubMed ID: 4202157
[No Abstract] [Full Text] [Related]
3. Halo nevus: competent surveillance of potential melanoma?
Krebs JA; Roenigk HH; Deodhar SD; Barna B
Cleve Clin Q; 1976; 43(1):11-5. PubMed ID: 1261030
[No Abstract] [Full Text] [Related]
4. Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma.
Hellström I; Warner GA; Hellström KE; Sjögren HO
Int J Cancer; 1973 Mar; 11(2):280-92. PubMed ID: 4790696
[No Abstract] [Full Text] [Related]
5. Antiserum against tyrosinase from mouse melanoma.
Ohtaki N; Miyazaki K
J Invest Dermatol; 1972 Apr; 58(4):238-41. PubMed ID: 4623203
[No Abstract] [Full Text] [Related]
6. The tyrosinases of normal and diseased human skin (naevi, malignant melanoma, vitiligo).
Voulot C; Ortonne JP
Arch Dermatol Res (1975); 1975 Dec; 254(2):205-14. PubMed ID: 814859
[TBL] [Abstract][Full Text] [Related]
7. In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma.
Jehn UW; Nathanson L; Schwartz RS; Skinner M
N Engl J Med; 1970 Aug; 283(7):329-33. PubMed ID: 4193645
[No Abstract] [Full Text] [Related]
8. Comparison of cell-mediated immunity to melanoma cells in patients with vitiligo, halo nevi or melanoma.
Mitchell MS; Nordlund JJ; Lerner AB
J Invest Dermatol; 1980 Aug; 75(2):144-7. PubMed ID: 7410884
[No Abstract] [Full Text] [Related]
9. The halo naevus and malignant melanoma.
Lancet; 1973 May; 1(7810):982. PubMed ID: 4121601
[No Abstract] [Full Text] [Related]
10. Dopa stain for precipitins in gel.
Madhosingh C; Wood IM
Anal Biochem; 1971 Dec; 44(2):523-7. PubMed ID: 4108687
[No Abstract] [Full Text] [Related]
11. [Delayed hypersensitivity reaction in malignant melanoma].
Gorodilova VV; Saraeva ZM; Slesareva RI; Monzul' GD
Vopr Onkol; 1973; 19(3):23-7. PubMed ID: 4762691
[No Abstract] [Full Text] [Related]
12. Immunological associations of the halo naevus with cutaneous malignant melanoma.
Copeman PW; Lewis MG; Phillips TM; Elliott PG
Br J Dermatol; 1973 Feb; 88(2):127-37. PubMed ID: 4574770
[No Abstract] [Full Text] [Related]
13. Tyrosinase activity in dermal nevus cells.
Thorne EG; Mottaz JH; Zelickson AS
Arch Dermatol; 1971 Dec; 104(6):619-24. PubMed ID: 4117664
[No Abstract] [Full Text] [Related]
14. Epithelial membrane antigen staining of melanocytic nevi.
Cramer SF
Hum Pathol; 1990 Jan; 21(1):121-2. PubMed ID: 2295503
[No Abstract] [Full Text] [Related]
15. Desmoplastic melanocytic nevi with lymphocytic aggregates.
Kiuru M; Patel RM; Busam KJ
J Cutan Pathol; 2012 Oct; 39(10):940-4. PubMed ID: 22845683
[TBL] [Abstract][Full Text] [Related]
16. Multiple congenital giant nevocellular nevi with halos. A clinical and electron microscopic study.
Berger RS; Voorhees JJ
Arch Dermatol; 1971 Nov; 104(5):515-21. PubMed ID: 5000972
[No Abstract] [Full Text] [Related]
17. Melanoma specific protein: occurrence in the urine of patients with halo naevus and vitiligo.
Cooke KB; Bennett C; Staughton RC
Br J Dermatol; 1978 Jun; 98(6):663-8. PubMed ID: 678452
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of human monoclonal antibody (2-139-1) in cutaneous melanocytic neoplasms in fixed tissue sections.
White WL; Tam ST; Mitchell MS; Yu MC; Kan-Mitchell J
J Histochem Cytochem; 1991 Jun; 39(6):777-85. PubMed ID: 1709658
[TBL] [Abstract][Full Text] [Related]
19. Specificity of tumor-associated antibodies in sera of patients with uveal melanoma.
Brownstein S; Phillips TM; Lewis MG
Can J Ophthalmol; 1978 Jul; 13(3):190-3. PubMed ID: 698890
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous regression of multiple melanocytic nevi after melanoma: report of 3 cases.
Martín JM; Pinazo I; Monteagudo C; Markovic J; Allende A; Jordá E
Am J Dermatopathol; 2014 Nov; 36(11):e183-8. PubMed ID: 25343215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
